1. Amiya T, Bando H (1988) Aconitum alkaloids. In: Brossi A (ed) The alkaloids, vol 34. Academic Press, San Diego, pp 95–179
2. Joshi BS, Pelletier SW (1999) Recent developments in the chemistry of norditerpenoid and diterpenoid alkaloids. In: Pelletier SW (ed) Alkaloids: chemical and biological perspectives, vol 13. Pergamon, Amsterdam, pp 289–370
3. Benn MH, Jacyno JM (1983) The toxicology and pharmacology of diterpenoid alkaloids. In: Pelletier SW (ed) Alkaloids: chemical and biological perspectives, vol 1. Wiley-Interscience, New York, pp 153–210
4. Fu M, Wu M, Qiao Y, Wang Z (2006) Toxicological mechanisms of Aconitum alkaloids. Pharmazie 61:735–741
5. Wada K, Ishizuki S, Mori T, Bando H, Murayama M, Kawahara N (1997) Effects of alkaloids from Aconitum yesoense var. macroyesoense on cutaneous blood flow in mice. Biol Pharm Bull 20:978–982
6. Wada K, Ishizuki S, Mori T, Fujihira E, Kawahara N (1998) Effects of Aconitum alkaloid kobusine and pseudokobusine derivatives on cutaneous blood flow in mice. Biol Pharm Bull 21:140–146
7. Wada K, Ishizuki S, Mori T, Fujihira E, Kawahara N (2000) Effects of Aconitum alkaloid kobusine and pseudokobusine derivatives on cutaneous blood flow in Mice; II. Biol Pharm Bull 23:607–615
8. Meng LH, Zhang JS, Ding J (2001) Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme- DNA cleavage complexes. Biochem Pharmacol 62:733–741
9. Qing C, Jiang C, Zhang JS, Ding J (2001) Induction of apoptosis in human leukemia K-562 and gastric carcinoma SGC-7901 cells by salvicine, a novel anticancer compound. Anticancer Drugs 12:51–56
10. Didelot C, Mirjolet JF, Barberi-Heyob M, Ramacci C, Merlin JL (2002) Radiation could induce p53-independent and cell cycle— unrelated apoptosis in 5-fluorouracil radiosensitized head and neck carcinoma cells. Can J Physiol Pharmacol 80:638–643
11. Baumann M, Krause M (2004) Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results. Radiother Oncol 72:257–266
12. Haveman J, Castro-Kreder N, Rodermond HM, van Bree C, Franken NA, Stalpers LJ, Zdzienicka MZ, Peters GJ (2004) Cellular response of X-ray sensitive hamster mutant cell lines to gemcitabine, cisplatin and 5-fluorouracil. Oncol Rep 12:187–192
13. Sonnemann J, Gekeler V, Ahlbrecht K, Brischwein K, Liu C, Bader P, M  ̈ller C, Niethammer D, Beck JF (2004) Down-regu- lation of protein kinase Cg by antisense oligonucleotides sensi- tises A549 lung cancer cells to vincristine and paclitaxel. Cancer Lett 209:177–185
14. Zhang M, Boyer M, Rivory L, Hong A, Clarke S, Stevens G, Fife K (2004) Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells. Int J Radiat Oncol Biol Phys 58:353–360
15. Kvols LK (2005) Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets. J Nucl Med 46:187S–190S
16. Pauwels B, Korst AEC, Andriessen V, Baay MFD, Pattyn GGO, Lambrechts HAJ, de Pooter CMJ, Lardon F, Vermorken JB (2005) Unraveling the mechanism of radiosensitization by gemcitabine: the role of TP53. Radiat Res 164:642–650
17. Chodoeva A, Bosc JJ, Guillon J, Decendit A, Petraud M, Absalon C, Vitry C, Jarry C, Robert J (2005) 8-O-Azeloyl-14-benzoyla- conine: a new alkaloid from the roots of Aconitum karacolicum Rapcs and its antiproliferative activities. Bioorg Med Chem 13:6493–6501
18. de In  ́s C, Reina M, Gav  ́n JA, Gonz  ́lez-Coloma A (2006) In vitro cytotoxicity of norditerpenoid alkaloids. Z Naturforsch C 61:11–18
19. Wada K, Hazawa M, Takahashi K, Mori T, Kawahara N, Kashiwakura I (2007) Inhibitory effects of diterpenoid alkaloids on the growth of A172 human malignant cells. J Nat Prod 70:1854–1858
20. Hazawa M, Wada K, Takahashi K, Mori T, Kawahara N, Kashiwakura I (2009) Suppressive effects of novel derivatives prepared from Aconitum alkaloids on tumor growth. Invest New Drugs 27:111–119
21. Hazawa M, Takahashi K, Wada K, Mori T, Kawahara N, Kashiwakura I (2009) Structure–activity relationships between the Aconitum C 20 -diterpenoid alkaloid derivatives and the growth suppressive activities of non-Hodgkin’s lymphoma Raji cells and human hematopoietic stem/progenitor cells. Invest New Drugs (in press). doi:10.1007/s10637-009-9327-4
22. Wada K, Bando H, Amiya T (1985) Two new C 20 -diterpenoid alkaloids from Aconitum yesoense var. macroyesoense (Nakai) Tamura. Structures of dehydrolucidusculine and N-deethyldehy- drolucidusculine. Heterocycles 23:2473–2477
23. Bando H, Wada K, Amiya T, Kobayashi K, Fujimoto Y, Sakurai T (1987) Studies on Aconitum species V. Constituents of Aconitum yesoense var. macroyesoense (Nakai) Tamura. Heterocycles 26:2623–2637
24. Wada K, Bando H, Kawahara N (1990) Studies on Aconitum species XIII. Two new diterpenoid alkaloids from Aconitum yesoense var. macroyesoense (Nakai) Tamura. VI. Heterocycles 31:1081–1088
25. Ogura H, Tsukumo Y, Sugimoto H, Igarashi M, Nagai K, Kataoka T (2008) ERK and p38 MAP kinase are involved in downregulation of cell surface TNF receptor 1 induced by acet- oxycycloheximide. Int Immunopharmacol 8:922–926
26. Lee JW, Min HY, Han AR, Chung HJ, Park EJ, Park HJ, Hong JY, Seo EK, Lee SK (2007) Growth inhibition and induction of G1 phase cell cycle arrest in human lung cancer cells by a phe- nylbutenoid dimer isolated from Zingiber cassumunar. Biol Pharm Bull 30:1561–1564
27. Nguyen TT, Tran E, Ong CK, Lee SK, Do PT, Huynh TT, Nguyen TH, Lee JJ, Tan Y, Ong CS, Huynh H (2003) Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK. J Cell Physiol 197:110–121
28. Nakagawa M, Oliva JL, Kothapalli D, Fournier A, Assoian RK, Kazanietz MG (2005) Phorbol ester-induced G 1 phase arrest selectively mediated by protein kinase Cd-dependent induction of p21. J Biol Chem 280:33926–33934